Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.1200 (-4.79%) ($13.7300 - $15.5400) on Tue. Sep. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 64 | Latest Price | $14.1200(-4.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2% a day on average for past five trading days. | Weekly Trend | ATRA advances 7.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.005% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-10%) UUP(-9%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
Resistance Level | $14.21 | 5 Day Moving Average | $15.26(-7.47%) | 10 Day Moving Average | $15.11(-6.55%) | 20 Day Moving Average | $14.21(-0.63%) | To recent high | -11% | To recent low | 19.3% | Market Cap | $1.049b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |